Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?"
Osteoporos Int. 2024 Nov;35(11):2071-2072.
doi: 10.1007/s00198-024-07192-4.
Epub 2024 Aug 16.
1 Unit of Oral Medicine and Dentistry for Fragile Patients, Department of Rehabilitation, Fragility and Continuity of Care, University Hospital Palermo, Palermo, Italy. [email protected].
2 Unit of Oral Medicine and Dentistry for Fragile Patients, Department of Rehabilitation, Fragility and Continuity of Care, University Hospital Palermo, Palermo, Italy.
3 Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, Palermo, Italy.
4 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
5 Regional Center for Prevention, Diagnosis and Treatment of Medication and Radiation-Related Bone Diseases of the Head and Neck, University of Padua, Padua, Italy.
6 Department of Neuroscience, University of Padova, Padua, Italy.
7 Department of Medicine, University of Verona, Verona, Italy.
8 Oncology Unit, Azienda Ospedaliera di Alessandria SS, Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.